BDBM515748 US11053219, Example 198::US11731956, Example 198

SMILES CCC(=O)c1cnc(Nc2cccc(n2)C#N)cc1Nc1cccc(-c2ncn(C)n2)c1OC

InChI Key InChIKey=IRFKFMWHMPYLQP-UHFFFAOYSA-N

Data  1 IC50  7 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 515748   

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataKd: <1nMAssay Description:DiscoverX's KINOMEscan™ is a popular platform for kinase profiling, frequently used in academic and industry witnessed by publications, ther...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataKd: <100nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataKd: >1.00E+4nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataKd: <1nMAssay Description:Developed by DiscoverX, KINOMEscan employs proprietary active-site dependent competition binding assays to determine how compounds bind to kinases. K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataKd: <100nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataKd: >1.00E+4nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataKd: >1.00E+4nMAssay Description:Binding affinity to JAK2 JH1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515748(US11053219, Example 198 | US11731956, Example 198)
Affinity DataIC50: 100nMAssay Description:Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 levelMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed